Drug Profile
Research programme: type-I interferons - Alios BioPharma
Alternative Names: Beta-Gly; Glycoferon; Hyperglycosylated type I interferons - Alios BioPharma; OncoferonLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Alios BioPharma
- Class Interferons
- Mechanism of Action Interferon type I stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis C; Malignant melanoma; Multiple sclerosis
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Hepatitis-C in USA (SC, Injection)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Malignant-melanoma in USA (SC, Injection)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Multiple-sclerosis in USA (SC, Injection)